Source: Annual Congress 2003 - Clinical pathobiology in diffuse and in neoplastic disorders
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
K. Hiroshima, A. Iyoda, K. Shibuya, Y. Haga, T. Toyozaki, M. Shiba, T. Nakayama, T. Fujisawa, H. Ohwada (Chiba, Japan). Genetic alterations in early sage of pulmonary large cell neuroendocrine carcinoma. Eur Respir J 2003; 22: Suppl. 45, 1684

Member's Comments

No comment yet.

Related content which might interest you: Cytological characteristics of pulmonary large cell neuroendocrine carcinoma Source: Eur Respir J 2004; 24: Suppl. 48, 82s Year: 2004 Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas Source: Eur Respir J 2004; 24: Suppl. 48, 557s Year: 2004 Clinical characteristics of large cell neuroendocrine carcinoma of the lung Source: Eur Respir J 2004; 24: Suppl. 48, 531s Year: 2004 Clinical characterization of non-small cell lung cancer tumors showing neuroendocrine differentiation Source: Eur Respir J 2002; 20: Suppl. 38, 270s Year: 2002 Intussusception of small intestine due to metastasis of large cell carcinoma of the lung with a rhabdoid phenotype Source: Eur Respir Rev 2010 19: 248-252 Year: 2010 Large cell neuroendocrine carcinoma of the lung: Experience with 20 resected cases Source: Eur Respir J 2003; 22: Suppl. 45, 250s Year: 2003 Large cell carcinoma Source: Annual Congress 2004 - PG15 - Understanding the WHO 2004 histopathological classification of lung tumours and its clinical utility Year: 2004 Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the role of neuroendocrine cells in airway remodelling Source: Annual Congress 2003 - The vital role of neuroendocrine cells in lung development and neoplasia Year: 2003 Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour Source: Eur Respir J, 59 (1) 2101058; 10.1183/13993003.01058-2021 Year: 2022 Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Large adrenal metastasis in non small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 94s Year: 2006 Borderline early squamous cell lung cancer Source: ISSN=ISSN 1810-6838, ISBN=, page=157 Year: 2004 Dopaminergic markers in human small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 231s Year: 2002 Clinicopathological prognostic factors in operated for small cell lung carcinoma or large cell neuroendocrine carcinoma patients Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 COX-2 expression during early lung squamous cell carcinomas oncogenesis Source: Eur Respir J 2005; 26: Suppl. 49, 456s Year: 2005 Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter? Source: Eur Respir J, 49 (6) 1601838; 10.1183/13993003.01838-2016 Year: 2017 Clinical features of large cell neuroendocrine carcinoma: a population-based overview Source: Eur Respir J 2016; 47: 615-624 Year: 2016 Expression of protein onkological marker onkoprobe in peripheral blood in cases of tracheal invasion and lung metastases of thyroid carcinoma Source: Eur Respir J 2002; 20: Suppl. 38, 466s Year: 2002 Distinct angiogenic and non-angiogenic growth patterns of lung metastases (LM) from renal cell carcinoma (RCC) Source: Eur Respir J 2003; 22: Suppl. 45, 362s Year: 2003